Spire Healthcare Group Plc (LON:SPI) insider Peter R. Bamford bought 5,000 shares of the business’s stock in a transaction dated Monday, November 27th. The shares were acquired at an average cost of GBX 240 ($3.16) per share, for a total transaction of £12,000 ($15,783.24).

Shares of Spire Healthcare Group Plc (SPI) traded down GBX 1.10 ($0.01) during trading hours on Monday, reaching GBX 237.30 ($3.12). The company had a trading volume of 887,960 shares, compared to its average volume of 3,590,000. Spire Healthcare Group Plc has a 52 week low of GBX 218.20 ($2.87) and a 52 week high of GBX 369 ($4.85).

Spire Healthcare Group (LON:SPI) last announced its quarterly earnings data on Thursday, September 14th. The company reported GBX 8.70 ($0.11) earnings per share (EPS) for the quarter, topping the consensus estimate of GBX 8.60 ($0.11) by GBX 0.10 ($0.00). Spire Healthcare Group had a return on equity of 1.71% and a net margin of 1.85%. The company had revenue of £481 million for the quarter.

The company also recently disclosed a dividend, which will be paid on Tuesday, December 12th. Investors of record on Thursday, November 16th will be paid a GBX 1.30 ($0.02) dividend. The ex-dividend date is Thursday, November 16th. This represents a yield of 0.5%.

A number of research analysts have recently commented on the company. Liberum Capital reaffirmed a “hold” rating and set a GBX 270 ($3.55) target price on shares of Spire Healthcare Group in a research note on Thursday, November 16th. Numis Securities Ltd reaffirmed an “add” rating and set a GBX 341 ($4.49) target price on shares of Spire Healthcare Group in a research note on Monday, October 23rd. Jefferies Group LLC cut their target price on Spire Healthcare Group from GBX 350 ($4.60) to GBX 259 ($3.41) and set a “hold” rating on the stock in a research note on Monday, September 25th. Berenberg Bank reaffirmed a “hold” rating and set a GBX 270 ($3.55) target price on shares of Spire Healthcare Group in a research note on Thursday, September 21st. Finally, J P Morgan Chase & Co cut their target price on Spire Healthcare Group from GBX 376 ($4.95) to GBX 339 ($4.46) and set a “neutral” rating on the stock in a research note on Friday, September 15th. One research analyst has rated the stock with a sell rating and six have issued a hold rating to the company’s stock. The company currently has an average rating of “Hold” and a consensus price target of GBX 304.14 ($4.00).

ILLEGAL ACTIVITY NOTICE: “Spire Healthcare Group Plc (SPI) Insider Peter R. Bamford Purchases 5,000 Shares” was first posted by Daily Political and is the sole property of of Daily Political. If you are reading this article on another publication, it was illegally copied and reposted in violation of US & international trademark and copyright legislation. The legal version of this article can be viewed at https://www.dailypolitical.com/2017/11/27/spire-healthcare-group-plc-spi-insider-peter-r-bamford-purchases-5000-shares.html.

About Spire Healthcare Group

Spire Healthcare Group plc is a United Kingdom-based independent hospital group. The Company provides in-patient, daycase and out-patient care from approximately 40 hospitals, 10 clinics and over two specialist care centers across the United Kingdom. The Company also owns and operates a sports medicine, physiotherapy and rehabilitation brand, Perform, and a screening service, Lifescan, as well as national pathology services.

Receive News & Ratings for Spire Healthcare Group Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spire Healthcare Group Plc and related companies with MarketBeat.com's FREE daily email newsletter.